Sangamo BioSciences Logo
Sangamo BioSciences

Sangamo in the News

Type 1 Discovery, Issue 54 Winter 2010/11
Partners for a better life.

  • About Us
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Sangamo in the News
    • Contact Us
  • Product Pipeline
    • SB-728
    • SB-313
    • Hemophilia
    • Huntington’s disease
    • Rare Diseases
    • Clinical Trials
    • Publications
  • Technology Platform
    • ZFP Transcription Factors
    • ZFP Nucleases
    • Therapeutic Applications
    • Non-Therapeutic Applications
    • Publications
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor FAQs
    • Contact Us
  • Careers
    • Job Opportunities
    • Benefits
About Us
  • Management
    • Edward Lanphier
    • Geoffrey Nichol, M.B.,Ch.B.
    • Ward Wolff
    • David G. Ichikawa
    • Dale Ando, M.D.
    • Philip D. Gregory, D. Phil.
  • Board of Directors
    • William Ringo
    • Paul Cleveland
    • Stephen Dilly, M.B.B.S., Ph.D.
    • Edward Lanphier
    • John Larson
    • Steven Mento, Ph.D
    • Saira Ramasastry
  • Scientific Advisory Board
    • Judith Campisi, Ph.D.
    • Barrie Carter, Ph.D.
    • Michael Gilman, Ph.D.
    • Sir Aaron Klug, O.M., F.R.S.
    • Gabor M. Rubanyi, M.D., Ph.D.
    • Kevin Struhl, Ph.D.
    • Keith Yamamoto, Ph.D.
  • Business Development
    • Existing Partnerships
    • Research Collaborations
  • Sangamo in the News
  • Contact Us
    • From Oakland Airport
    • From Downtown San Francisco
    • From San Francisco International Airport
© sangamo.com     Website design: Hane Chow Inc.
  • Terms Of Use
  • Privacy
  • Legal Notice